| Catalog Number |
PR5743282 |
| CAS |
5743-28-2 |
| Synonyms |
Calcium ascorbate dihydrate |
| IUPAC Name |
calcium;(2R)-2-[(1S)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2H-furan-4-olate;dihydrate |
| Molecular Weight |
426.34 |
| Molecular Formula |
C12H18CaO14 |
| InChI |
InChI=1S/2C6H8O6.Ca.2H2O/c2*7-1-2(8)5-3(9)4(10)6(11)12-5;;;/h2*2,5,7-10H,1H2;;2*1H2/q;;+2;;/p-2/t2*2-,5+;;;/m00.../s1 |
| InChI Key |
RGJHWLDSRIHFKY-FWCDDDAWSA-L |
| Drug Categories |
Acids, Acyclic; Antioxidants; Biological Factors; Carbohydrates; Compounds used in a research, industrial, or household setting; Diet, Food, and Nutrition; Food; Hydroxy Acids; Micronutrients; Physiological Phenomena; Protective Agents; Sugar Acids; Urinary Acidifying Agents; Vitamin C and analogues; Vitamins |
| Drug Interactions |
Amphetamine-The serum concentration of Amphetamine can be decreased when it is combined with Calcium ascorbate.
Benzphetamine-The serum concentration of Benzphetamine can be decreased when it is combined with Calcium ascorbate.
Bleomycin-The therapeutic efficacy of Bleomycin can be decreased when used in combination with Calcium ascorbate.
Bortezomib-The therapeutic efficacy of Bortezomib can be decreased when used in combination with Calcium ascorbate.
Chlorpropamide-Calcium ascorbate may decrease the excretion rate of Chlorpropamide which could result in a higher serum level. |
| EC Number |
227-261-5 |
| Isomeric SMILES |
C([C@@H]([C@@H]1C(=C(C(=O)O1)[O-])O)O)O.C([C@@H]([C@@H]1C(=C(C(=O)O1)[O-])O)O)O.O.O.[Ca+2] |
| Packaging |
25kg/carton |
| Standard |
USP/FCC/E302 |
| Type |
Small Molecule |
It should be noted that our service is only used for research, not for clinical use.
